glp 1 approved for heart disease Glucagon-like Peptide-1 Receptor Agonists in Failure Glucagon-Like Peptide-1 Agonist Use in

While a mild rash can occur at the injection site, a widespread or severe rash is uncommon and should be reported to a healthcare provider, as it may indicate an allergic reaction

Reduced fluid intake due to nausea and early satiety can contribute to dehydration risk

The GIP receptor plays an important role in regulating insulin and appetite, providing an additional mechanism for improved blood sugar control and appetite suppression

A small observational study (2023) in the journal *Obesity* suggested additive weight loss in a cohort of 47 patients on both agents, but sample size, lack of randomization, and absence of long-term follow-up prevent firm conclusions

Meanwhile, Eli Lilly has told The Pharmaceutical Journal that its next wave of research would be focused on the potential of tailoring therapies to patient subgroups through biomarkers and precision medicine to understand who benefits most from each mechanism